Staff writer, Hyunmi Park

Seegene concluded joint marketing contract with a US company

Seegene, INC., a bio venture company (CEO, Jong Yoon Chun), announced its joint marketing contract with VWR International of the US on Dec 15.

Seegene expects its annual revenue to be more than 10 million dollars in the US market by providing scientists in the US new technology products and service of gene discovery and gene function analysis.

VWR International is also expected to strengthen its reagent sector, who is already a global leader in the distribution of supplies in medicine and life science.

Seegene recorded 1.5 billion (KRW) of revenue this year in the domestic market, through the service of gene discovery and gene function analysis.